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Background: Prevalence of acute pulmonary embolism is
increasing in general population especially in old population.
Prevalence of acute pulmonary embolism in young adults is
unknown.The objective of this study was to assess the prevalence
of acute pulmonary embolism in young (<40 years) population and
to compare the clinical presentation and the therapeutic benefit in
regards to age at presentation. Settings: A single tertiary cardiac
care centre.
Methods: In this study, among 202 patients enrolled, 97 & 105
patients were admitted as young & old patient, respectively. The
clinical presentation and course after therapy among them were
observed and compared.
Results: forty-eight percent of our study population belongs to <40
years of age. There were no significant differences seen in func-
tional class, hypotension, electrocardiographic & echocardio-
graphic features based on age difference. Clinical improvement
after treatment (68% vs 78%, p¼0.42) and in hospital death (10% vs
16%, p¼0.36) was non-significantly more in older than in young
patients. Though the incidence of minor bleeding (14% vs 11%,
p¼0.68) was non-significantly higher in older group of patients but
two patients in this group had intra-cerebral bleed following
thrombolytic therapy.
Conclusion: As there were no significant differences in the clinical
presentation, therapeutic benefit, and course after therapy and
complication, therefore, age should not influence the decision to
treat pulmonary embolism patients especially with thrombolytic
agents though caution should be taken while treating older
patients.
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Background: In hypothyroidism there is reduced production of
thyroid hormone which leads to characteristic cardiovascular
clinical features including sinus bradycardia, diastolic hyperten-
sion, pericardial effusion, dyslipidemia, cardiomyopathy,
congestive heart failure, etc. So far our knowledge goes this study
is first of its kind in Upper Assam.
Methods: This study was undertaken in 79 patients with hypo-
thyroidism, diagnosed on the basis of clinical features and thyroid
function tests and were taken up for the study after considering
the inclusion and exclusion criteria. This was a hospital based
observational study.
Results: 79 patients with hypothyroidism were included in the
study. The mean age of patients was 42.59 ± 14.15 years and
74.68% were females. The most common symptoms of hypo-
thyroidism in the patients were fatigue (59.49%), followed by
lethargy (55.70%). Cardiovascular involvement was present in
68.35% patients. The most common symptom of cardiovascular
involvement was effort intolerance (35.44%) followed by chest
pain (21.53%). Diastolic hypertension (34.18%) and sinus brady-
cardia (25.32%) were the most common cardiovascular signs in
the patients. Pearson correlation showed a positive correlation
between the number of symptoms in the patients and the serum
TSH level. Linear regression analysis also showed a significant
correlation between serum TSH and serum levels of total
cholesterol, LDL cholesterol and triglycerides (p value <0.05). The
most common ECG abnormality was sinus bradycardia and the
most common abnormality on Echocardiography was LV dia-
stolic dysfunction (34.18%). Holter monitoring revealed QT pro-
longation with evidence of non-sustained ventricular tachycardia
in 1 patient (1.27%), and Tread mill test was positive in 1 patient
(1.27%).
Conclusion: Cardiovascular manifestations are common in hy-
pothyroid patients which may lead to serious life threatening
arrhythymias and could gradually progress to preventable overt
heart failure.
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Background: Pulmonary embolism (PE) remains a medical emer-
gency, in massive pulmonary embolism and consequent right
ventricular failure, where restoration of pulmonary arterial flow is
urgently required, prompt therapeutic intervention is imperative.
Thrombolytic therapy has a potential to produce quick throm-
bolysis, improve hemodynamic instability and eliminate the
venous thrombi.Despite the approval of streptokinase, urokinase,
alteplase and tenecteplase for thromolysis in PE, the efficacy of
these thromolytics remain unclear due to the high mortality
associated with this condition.
Methods and Results: The 120 cases admitted with suspected
pulmonary embolism, only 68% (96) patients were thrombolysed,
rest 32% (44) were not thrombolysed due to old age , embolisation
in smaller lobar vessels and affordability of the patients. Total
enrolled patients were 105 males and 35 females of which 72
males and 24 females were thrombolysed. The presenting symp-
toms of dyspnoea, chest pain, hemoptysis and syncope were
found in 140(100%), 7 (5%), 0(0%) and 28 (20%) patients
respectively.
According to Well’s score for pretest probability of pulmonary
embolism, 5 % patients had high probability (Well’s score>6), 55%
patients had moderate probability (Well’s score between 2 and 6)
and 40% patient had low probability (Well’s score<2). The diag-
nosis of pulmonary embolism could be confirmed only in 8% pa-
tients using CT pulmonary angiography. In others, pulmonary
embolism was the most likely diagnosis based on Well’s score,
abnormal X-ray findings and evidence of right ventricular wall
stress on 2D-echocardiography.
The signs of right heart failure documented were raised jugular
venous pressure (46%), hepatomegaly (3%) and pleural effusion
(5%). The ECG findings included S1Q3T3 pattern (60%), right
bundle branch block (15%), and ST-T changes (25%).
The baseline echocardiography findings included evidence of
thrombus in pulomonary artery (15%), right atrium (5%), dilated
right ventricle (95%) and tricuspid regurgitation (55%).
In our study the efficacy of the thrombolytic agents used and the
complications associated with them did not show any significant
discrepancies. The two hour regimen of streptokinase which was
used in patients showed to be quite effective as well.
Conclusion: Because of the high cost and serious bleeding com-
plications that may arise with thrombolytic therapy, thrombolytic
treatment should be reserved for patients with massive PE
complicated by severe haemodynamic compromise.
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